Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Why The National Vet Care (ASX:NVL) Share Price Is Up 2%

The National Veterinary Care Ltd (ASX:NVL) share price has gone up 2% after announcing some more acquisitions. 

The National Veterinary Care Ltd (ASX: NVL) share price has gone up 2% after announcing some more acquisitions.

National Veterinary Care wants to be the biggest veterinary business in Australia. It has acquired and integrated 100 veterinary services businesses across Australia and New Zealand. It’s still looking to expand its clinic portfolio through acquisitions and increase earnings organically at each existing clinic.

National Veterinary Care’s Latest Acquisitions

The veterinary business announced this morning that it has entered into binding agreements to acquire veterinary clinics in two locations, one in Australia and one in New Zealand.

These new acquisitions are in existing National Vet Care’s geographic clusters. The New Zealand is a ‘strategic’ acquisition for consolidation with a smaller Pet Doctors clinic to achieve a larger & more sustainable clinic.

The two acquisitions are expected to deliver total revenue of around $2.45 million and total annual EBIT (click here to learn what EBIT means) of around $0.47 million.

Total cost for the acquisition will be $1.94 million, $1.34 million upfront and the rest deferred based partially on earnout conditions.

The acquisitions are still conditional on due diligence, board approval and lease assignments, with settlements expected by the end of November 2019, which will bring the total to 102.

National Veterinary Care Managing Director Tomas Steenackers said: “The New Zealand acquisition provides an opportunity for us to improve the sustainability and secure the future of a smaller nearby Pet Doctors clinic, which is a growth strategy we have previously had some success with in Australia.”

Is The National Veterinary Care Share Price A Buy?

Over the past six months the National Vet Care share price has gone up by 37% as investors return to the small cap space.

A roll-up strategy is not the most compelling business case on the ASX, but National Vet Care certainly isn’t a terrible idea as same clinic revenue increases and FY20 is expected to show 20% revenue growth with a higher profit margin.

It’s valued at around 20 times the 2019 financial year earnings, so it’s priced quite nicely for growth over the next couple of years. But if you’re after the best ASX growth shares it could be better to go for the ones in the free report below instead.

[ls_content_block id=”18457″ para=”paragraphs”]

[ls_content_block id=”18380″ para=”paragraphs”]

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content